Schroder Investment Management Group Puma Biotechnology, Inc. Transaction History

Schroder Investment Management Group

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$9.5 - $11.14 $1.16 Million - $1.36 Million	-121,876 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.01 - $13.24 $854,350 - $1.61 Million	121,876 New	121,876 $1.27 Million
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $2.42 Million - $5.63 Million	-120,640 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$41.2 - $59.85 $7,539 - $10,952	183 Added 0.15%	120,640 $5.53 Million
Q2 2018 Aug 24, 2018	SELL	$48.3 - $68.25 $167 Million - $236 Million	-3,457,367 Reduced 96.63%	120,457 $6.79 Million
Q2 2018 Aug 13, 2018	BUY	$48.3 - $68.25 $156 Million - $221 Million	3,232,859 Added 937.16%	3,577,824 $63.3 Million
Q1 2018 May 11, 2018	BUY	$59.7 - $99.25 $189,547 - $315,118	3,175 Added 0.93%	344,965 $23.5 Million
Q4 2017 Feb 09, 2018	SELL	$93.85 - $132.45 $429,739 - $606,488	-4,579 Reduced 1.32%	341,790 $33.8 Million
Q3 2017 Nov 09, 2017	BUY	$72.0 - $119.75 $24.9 Million - $41.5 Million	346,369	346,369 $40.6 Million

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.